scholarly journals Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide.

1991 ◽  
Vol 266 (11) ◽  
pp. 6714-6719
Author(s):  
M R Wessels ◽  
J L DiFabio ◽  
V J Benedì ◽  
D L Kasper ◽  
F Michon ◽  
...  
2008 ◽  
Vol 15 (9) ◽  
pp. 1420-1424 ◽  
Author(s):  
Rooyen T. Mavenyengwa ◽  
Johan A. Maeland ◽  
Sylvester R. Moyo

ABSTRACTThe distribution of capsular polysaccharide (CPS) types and subtypes (serovariants) among 121 group B streptococcus (GBS) strains from Zimbabwe was examined. PCR was used for the detection of both CPS types and the surface-anchored and strain-variable proteins Cα, Cβ, Alp1, Alp2, Alp3, R4/Rib, and Alp4. The R3 protein was detected by an antibody-based method using monoclonal anti-R3 antibody in dot blotting. The CPS types detected, Ia (15.7% of strains), Ib (11.6%), II (8.3%), III (38.8%), V (24.0%), and nontypeable (1.7%), were essentially as expected on the basis of data from Western countries. The type V strains showed distinctive features with respect to protein markers in that Alp3 was detected in only 6.9% of the isolates while R3 occurred in 75.9% and R4/Rib occurred in 37.9% of the isolates. R3 occurred nearly always in combination with one of the alpha-like (Alp) proteins, and it was the third most common of the proteins studied. These results show that type V GBS strains from Zimbabwe differed from type V strains from other geographical areas and also emphasize the importance of the R3 protein in GBS serotyping and its potential importance in the immunobiology of GBS, including a potential role in a future GBS vaccine.


1989 ◽  
Vol 57 (4) ◽  
pp. 1089-1094 ◽  
Author(s):  
M R Wessels ◽  
W J Benedí ◽  
H J Jennings ◽  
F Michon ◽  
J L DiFabio ◽  
...  

2006 ◽  
Vol 55 (6) ◽  
pp. 775-783 ◽  
Author(s):  
Srinivas V. Ramaswamy ◽  
Patricia Ferrieri ◽  
Lawrence C. Madoff ◽  
Aurea E. Flores ◽  
Nikhil Kumar ◽  
...  

Group B Streptococcus (GBS) is an important pathogen responsible for a variety of diseases in newborns and the elderly. A clinical GBS isolate is considered nontypable (NT) when serological methods fail to identify it as one of nine known GBS serotypes. Eight clinical isolates (designated A1–A4, B1–B4) showed PFGE profiles similar to that of a GBS serotype V strain expressing R1, R4 surface proteins. These unique isolates were further characterized by immunologic and genetic methods. Rabbit sera to isolates A1 and A2 reacted weakly with concentrated HCl extracts of A1–A4 isolates, but not with those of B1–B4 isolates. In addition, a type V capsular polysaccharide (CPS) inhibition ELISA revealed that cell wall extracts from isolates A1–A4, but not from B1–B4, expressed low but measurable amounts of type V CPS. Molecular serotyping with PCR analysis showed that all eight isolates contained a type V-specific CPS gene (cpsO) and harboured the gene encoding the surface protein Alp3. Multilocus sequence typing identified isolate A1 as belonging to a new sequence type (ST) designated ST-173, whereas the other seven isolates keyed to ST-1. Sequencing of the 18 genes (17 736 bp) in the cps locus showed that each NT isolate harboured one to three unique polymorphisms, and also identified an IS1381 element in cpsE of the B4 isolate. Collectively, genetic and immunologic analyses revealed that these NT isolates expressing R1, R4 proteins have a genetic profile consistent with that of type V, an emergent, antigenically diverse and increasingly prevalent GBS serotype.


1988 ◽  
Vol 10 (Supplement 2) ◽  
pp. S367-S371 ◽  
Author(s):  
D. G. Pritchard ◽  
M. L. Egan ◽  
B. M. Gray ◽  
H. C. Dillon

2012 ◽  
Vol 65 (6) ◽  
pp. 516-521 ◽  
Author(s):  
Hiroyuki Ueno ◽  
Yoshihiko Yamamoto ◽  
Akiko Yamamichi ◽  
Koji Kikuchi ◽  
Sumie Kobori ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document